GSE179235 MEK NRAS inhibition 5 v 7 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE179235_MEK_NRAS inhibition_5_v_7_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE179235_MEK_NRAS inhibition_5_v_7_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE179235_MEK_NRAS inhibition_5_v_7_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE179235_MEK_NRAS inhibition_5_v_7_human_up.

Results found

Linked to

 

Label

Description

 

Gene

zinc finger domain-containing protein LOC728743

Gene

long intergenic non-protein coding RNA 1615

Gene

CLN8 antisense RNA 1

Gene

BOLA3 divergent transcript

Gene

FAM151B divergent transcript

Gene

SLCO4A1 antisense RNA 1

Gene

ZNF436 antisense RNA 1

Gene

AQP5 and AQP2 antisense RNA 2

Gene

uncharacterized LOC124902280

Gene

SMG1 pseudogene 5

  • Gene

    zinc finger domain-containing protein LOC728743


  • Gene

    long intergenic non-protein coding RNA 1615


  • Gene

    CLN8 antisense RNA 1


  • Gene

    BOLA3 divergent transcript


  • Gene

    FAM151B divergent transcript


  • Gene

    SLCO4A1 antisense RNA 1


  • Gene

    ZNF436 antisense RNA 1


  • Gene

    AQP5 and AQP2 antisense RNA 2


  • Gene

    uncharacterized LOC124902280


  • Gene

    SMG1 pseudogene 5

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.